Terms: = Pancreatic cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Diagnosis
5 results:
1. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
2. Imaging of genetically-mediated pancreatitis.
O'Brien CM; O'Brien AC; Gleeson L; Conlon K; Feeney J; Malone DE
Clin Imaging; 2020 Sep; 65():113-118. PubMed ID: 32387800
[TBL] [Abstract] [Full Text] [Related]
3. Pyrosequencing-Based Assays for Rapid Detection of HER2 and her3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting her3 in Retroperitoneal Leiomyosarcoma.
González-Alonso P; Chamizo C; Moreno V; Madoz-Gúrpide J; Carvajal N; Daoud L; Zazo S; Martín-Aparicio E; Cristóbal I; Rincón R; García-Foncillas J; Rojo F
Int J Mol Sci; 2015 Aug; 16(8):19447-57. PubMed ID: 26287187
[TBL] [Abstract] [Full Text] [Related]
4. Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.
Mill CP; Gettinger KL; Riese DJ
Exp Cell Res; 2011 Feb; 317(4):392-404. PubMed ID: 21110957
[TBL] [Abstract] [Full Text] [Related]
5. Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas.
Friess H; Wang L; Zhu Z; Gerber R; Schröder M; Fukuda A; Zimmermann A; Korc M; Büchler MW
Ann Surg; 1999 Dec; 230(6):767-74; discussion 774-5. PubMed ID: 10615931
[TBL] [Abstract] [Full Text] [Related]
